Showing results (1761-1770 of 3,508) with videos related to
Sort By:
Pageof 351
International Immunology|March 1, 1993
CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation eventsJ Nunès, S Klasen, M Ragueneau, et al.Infection and Immunity|February 24, 2006
Role for the CD28 molecule in the control of Coxiella burnetii infectionAmélie Honstettre, Soraya Meghari, Jacques A Nunès, et al.European Journal of Clinical Pharmacology|April 17, 1979
Pharmacokinetics of clorazepate in pregnant and non-pregnant womenE Rey, P d'Athis, P Giraux, et al.BMJ (Clinical Research Ed.)|January 19, 2002
Effect of delays in primary care referral on survival of women with epithelial ovarian cancer: retrospective auditJohn M J Kirwan, Douglas G Tincello, Jonathan J O Herod, et al.Cancer Research|September 2, 2000
Human acute myeloid leukemia CD34+/CD38- progenitor cells have decreased sensitivity to chemotherapy and Fas-induced apoptosis, reduced immunogenicity, and impaired dendritic cell transformation capacitiesR T Costello, F Mallet, B Gaugler, et al.General Hospital Psychiatry|November 19, 2019
Depression, stress and vascular function from childhood to adolescence: A longitudinal investigationLisa S Olive, Walter P Abhayaratna, Don Byrne, et al.Cancer|October 1, 1984
Paraaortic lymphadenectomy is not necessary in the treatment of localized paratesticular rhabdomyosarcomaD Olive, F Flamant, J M Zucker, et al.Conflict and Health|January 7, 2021
A case analysis of partnered research on palliative care for refugees in Jordan and RwandaSonya de Laat, Olive Wahoush, Rania Jaber, et al.Therapeutic Drug Monitoring|January 1, 1988
Gentamicin monitoring in neonatesG Pons, P d'Athis, E Rey, et al.Frontiers in Immunology|April 10, 2014
Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor ActivityAnne-Sophie Chretien, Aude Le Roy, Norbert Vey, et al.Pageof 351